The Global Mammography Devices Market stood at USD 2744.07 million in 2020 and is expected to grow at a steady CAGR of 5.78% during the forecast period.

Image courtesy of ResearchAndMarkets


January 31, 2022 — The Global Mammography Devices Market stood at USD 2744.07 million in 2020 and is expected to grow at a steady CAGR of 5.78% during the forecast period, according to a new report from ResearchandMarkets.com, Global Mammography Devices Market, By Product Type (Full-field Digital Mammography, Film-screen Mammogram, Breast Tomosynthesis). The growth of mammography devices can be attributed to the growing prevalence of breast cancer across the globe. Cancer is a terminal disease and under many cases early diagnosis is very difficult, making it more life threatening. Mammography devices helps to identify any kind of lesions in the mammary glands which is used for the identification of the cancer. This in turn is expected to drive the market growth. Additionally, supportive government policies and initiatives across the globe to create awareness among the female population regarding breast cancer its symptoms is expected to fuel the market growth through 2026. Also, various non-governmental organizations, hospitals and other and public welfare organizations keep on organizing camps and awareness campaigns to spread awareness pertaining to breast cancer. All these factors are expected to positively influence the market in the next five years.

However, the sudden outbreak and spread of the COVID-19 pandemic has significantly impacted the growth of the Global Mammography Devices Market. The surge in COVID-19 cases worldwide led to development of fear among the population, people stopped visiting hospitals for regular health-checkups and diagnostic procedures. Additionally, the hospitals also stopped the functioning of general hospital care for non-COVID-19 patients and completely focused on COVID-19 patients across the globe. Above-mentioned factors are expected to negatively impact or hinder the growth of the Global Mammography Devices Market.

The Global Mammography Devices Market is segmented on the basis of product type, technology, end-user, and regional distribution. Based on technology, the market can be categorized into digital and analog. Among these, digital technology segment dominated the market in 2020 with an overall share of 69.90%. Growth in the segment can be ascribed to the rapid technological advancements, leading to the adoption and utilization of digital technology in the mammography devices. Although the technique is quite expensive, but the high precision and specificity offered makes it a popular choice across the globe. Digital mammography is a specialized and advanced form of mammography that uses digital receptors and computers instead of X-ray films to examine breast tissue for the presence of tumors.

Based on regional distribution, the market can be split into Europe, North America, Asia Pacific, South America and Middle East & Africa. Among these regions, Asia Pacific is expected to register the highest growth during the forecast period on account of the growing prevalence of breast cancer in the region. Additionally, increasing awareness pertaining to breast cancer and breast health is further strengthening the market growth in the region. In the Asia Pacific region, Australia observes the highest prevalence of breast cancer. The rate of breast cancer prevalence in Australia is around 94.5 per 100,000 of population which contributes to the dominant share of the country in the region.

Some of the major players in the market are Hologic Inc., Siemens Healthineers AG, Fujifilm Holdings Corporation, GE Healthcare (Smart Breast Corporation), Koninklijke Philips N.V., among others. The companies are focusing on extensive research and development activities to stay competitive in the market. Other competitive strategies include formation of alliances and partnerships.

For more information: www.researchandmarkets.com

Related Breast Imaging Content:

COVID-19 Vaccine Can Cause False Positive Cancer Diagnosis

Help Spread Awareness of Potential COVID-19 Vaccine Imaging Side-effects

VIDEO: COVID Vaccine May Cause Enlarged Lymph Nodes on Mammograms — Interview with Constance "Connie" Lehman, M.D.

COVID-19 Vaccination Axillary Adenopathy Detected During Breast Imaging

VIDEO: COVID Vaccine Adenopathy Can Last Up to 10 Weeks — Interview with Yael Eshet, M.D.

VIDEO: Artificial Intelligence Trends in Medical Imaging — Interview with Signify Research

Technology Report: Artificial Intelligence in Radiology 2021

Find more RSNA news and video

Related COVID-19 Cancer-care Information:

Female Breast Cancer Surpasses Lung as the Most Commonly Diagnosed Cancer Worldwide

Johns Hopkins Medicine Expert Weighs Devastating Impact of COVID-19 on Healthcare Workers

Radiation Oncologists Urge Congress to Advance Bills That Protect Patient Access to Cancer Care During Pandemic

Breast Imaging in the Age of Coronavirus


Related Content

News | Breast Density

February 6, 2023 — Awareness of breast density appears to increase one’s perceived breast cancer risk for a short time ...

Time February 06, 2023
arrow
News | Radiology Business

February 2, 2023 — Five additional imaging centers across Allegheny Health Network (AHN) have been recognized by the ...

Time February 02, 2023
arrow
News | MRI Breast

February 1, 2023 — Compared to other common supplemental screening methods, breast MRI was superior at detecting breast ...

Time February 01, 2023
arrow
News | Radiation Therapy

January 31, 2023 — Age-based heuristics can lead to large differences in breast cancer treatment based on small ...

Time January 31, 2023
arrow
Webinar | Information Technology

Postpandemic staffing shortages and increased volumes require radiologists to do more with less, exacerbating burnout ...

Time January 30, 2023
arrow
News | Stereotactic Breast Imaging

January 27, 2023 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR), both ...

Time January 27, 2023
arrow
News | Artificial Intelligence

January 26, 2023 — MedCognetics, Inc., an Artificial Intelligence (AI) software firm, announced that it has been awarded ...

Time January 26, 2023
arrow
News | Artificial Intelligence

January 23, 2023 — PreciseDx, a leading innovator in AI-powered, patient-specific disease analysis, announced its recent ...

Time January 23, 2023
arrow
Feature | Breast Density | By JoAnn Pushkin

Let’s start with an actual clue from a Jeopardy Tournament of Champions match: “The main cause of false negative results ...

Time January 19, 2023
arrow
Feature | RSNA | By Melinda Taschetta-Millane

The Radiological Society of North America’s (RSNA) 108th Scientific Assembly and Annual Meeting (RSNA22) took place at ...

Time January 16, 2023
arrow
Subscribe Now